Viw Magazine

Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering "Nuclear Power" to The Company’s Performance

  • Written by Viw Magazine
HONG KONG SAR - Media OutReach - 20 June 2022 - On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: 0512.HK)’s global innovative product, SIR-Spheres® Y-90 microsphere injection for the treatment of liver malignant tumors, was officially commercialized in Mainland China.

Read more

LifeStyle

The Benefits of Using Professional Skincare Brands

Professional skincare brands can take your skincare to the next level. The ingredients that have...

How Do I Find a Rheem Service Agent Near Me?

It’s been weeks (maybe months) of your hot water system playing up. It’s finally time to repla...

From Ancient Rites to Modern Tributes: The Enduring Tradition of Funeral Flowers

The practice of adorning the deceased with flowers is a time-honoured tradition that has spanned cul...

SMP Aftercare: Essential Tips for Maintaining Long-lasting Results

We are guessing you are happy with the results you just got from that Scalp Micropigmentation pr...